How Do You Lose Weight with Wegovy?

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight-loss benefits in clinical populations. The medication works by mimicking a natural hormone that regulates appetite and blood sugar, leading to sustained reductions in calorie intake and body weight. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, making personalized GLP-1 therapy accessible across all 50 states without insurance.

How Semaglutide Works for Weight Loss

Semaglutide activates GLP-1 receptors in the brain regions responsible for appetite control, hunger sensation, and fullness signals. When you take semaglutide, your body releases less ghrelin (the hunger hormone) and increases peptide YY, which signals satiety to your central nervous system. This dual mechanism reduces your desire to eat, decreases snacking between meals, and increases the amount of food needed to feel satisfied.

The medication also slows gastric emptying—the rate at which food moves from your stomach into your small intestine. This extended stomach residence time creates a prolonged feeling of fullness after smaller meals, making it easier to maintain a calorie deficit without constant hunger or deprivation. Over weeks of consistent use, this physiologic shift supports sustainable weight loss without extreme dietary restriction.

Clinical Evidence for Semaglutide Weight Loss Results

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trials demonstrated that people receiving semaglutide achieved average weight loss of 10-15% of baseline body weight compared to 2-3% in placebo groups. In the STEP 3 trial, participants maintained weight loss over 68 weeks, and continued treatment prevented weight regain during an additional maintenance phase. These results represent clinically meaningful improvements in cardiovascular risk factors, mobility, and metabolic health markers.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Dosing and Dose Escalation Strategy

Semaglutide therapy begins at a low starting dose to allow your body to adjust and minimize side effects, then increases gradually over several weeks in a structured titration schedule. Your provider adjusts your dose upward based on your tolerance, appetite suppression response, and weight-loss progress—not based on body weight or BMI thresholds. This personalized approach ensures you find your effective dose while maintaining tolerability.

PlexusDx compounds semaglutide injections at a flat monthly price of $189 at the starting tier, regardless of which dose level you eventually reach. Your dose may need to go up as your body adjusts, but your price won't increase—this ensures that dose optimization never becomes a financial barrier to reaching your target weight-loss outcome. Injection pens or syringes are administered once weekly, either by yourself or with provider guidance.

Managing Side Effects and Optimizing Your Weight Loss Journey

Common side effects during the first 2-4 weeks include mild nausea, reduced appetite for favorite foods, changes in bowel regularity, and fatigue. These effects typically diminish as your body adapts, though some people experience persistent mild nausea if their dose escalates too quickly. Eating smaller, frequent meals of protein-rich and hydration-focused foods, plus staying well-hydrated throughout the day, significantly reduces GI discomfort and supports consistent weight loss.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Compounded Semaglutide vs. Brand Wegovy: Access and Affordability

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which compound the medication in-house to exact specifications and ship directly to patients across all 50 states. This model eliminates insurance gatekeeping, prior authorization delays, and supply shortages that often limit access to brand-name Wegovy. PlexusDx compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan with no membership fee, no insurance requirement, and full HSA/FSA eligibility.

Both compounded and brand semaglutide use the same active pharmaceutical ingredient and work through identical biological mechanisms; the primary difference is access, cost, and personalization. PlexusDx adds genetic testing and provider-guided dose optimization at the same flat price, ensuring you receive the most effective dose for your body without paying more as your therapy advances. If you have insurance coverage for Wegovy, PlexusDx remains an affordable backup option; if you don't have coverage, PlexusDx makes GLP-1 therapy immediately available without prior authorization or insurance appeals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to see weight loss results with semaglutide?

Most PlexusDx patients notice reduced appetite and food cravings within 1-2 weeks of starting semaglutide injections. Measurable weight loss typically becomes visible on the scale by week 4-6, with steady monthly losses of 2-4 pounds. Results accelerate as your dose reaches therapeutic levels and your body fully adapts to the medication's appetite-suppressing effects.

What percentage of weight can you expect to lose with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does PlexusDx compounded semaglutide cost more as your dose increases?

No. PlexusDx charges a flat monthly rate at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injections, regardless of your dose level. Your dose may need to go up as treatment progresses, but your price won't—this pricing model ensures dose optimization is never blocked by cost concerns.

Is compounded semaglutide safe, and does it work as well as brand Wegovy?

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies regulated by state boards and the FDA. Compounded semaglutide contains the identical active ingredient as Wegovy and produces equivalent appetite suppression and weight loss when dosed appropriately. The main differences are access speed and affordability—PlexusDx delivers therapy without insurance requirements or prior authorization delays.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.